Webinar: Training Trusted Messengers

AIM, iREACH and Partnering for Vaccine Equity (P4VE) present this informative webinar with Dr. Dan will address the following questions: What is a trusted messenger? Who is the ideal trusted…

First Approved Oral Antiviral Pill for COVID-19 Disease

This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.

Understanding Implicit Bias Webinar

On September 14, 2021, AIM hosted the second in a series of webinars focused on diversity, equity, and inclusion. This session discussed implicit bias and helped participants recognize the role…

Understanding DEI Terms/Definitions Webinar

On August 31, 2021, AIM, Klapperich International Training Associates (KITA) and People Strategies Hawai’i facilitated the first session of a Diversity, Equity, and Inclusion webinar series. This session provided a…

FDA Authorized vs FDA Approved

This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.
Back To Top
Search